
Faculty
University Catalogue
Faculty Manual
Faculty Housing
Expatriate Immigration Guide
Strategic Planning 2008-2013
University Policies & Procedures
University Telephone Directory
Faculty
Dr.
Jose Rey-Ladino
Professor of Microbiology and Immunology
College of Medicine
Alfaisal University
Riyadh, KSA
Email: jladino@alfaisal.edu
Tel : +(966-1) 215-7654 office
| Education: |
|
|
| Ph.D (Microbiology and Immunology) |
1996 |
University of British Columbia, Canada |
| Ph.D (Parasitology) |
1982 |
Saint Petersburg Veterinary Institute, Russia |
| B.Sc (Biology) |
1976 |
University of Los Andes, Colombia |
| |
|
|
Awards and Honors
- Young Investigator Award, American Association of Clinical
Investigation, USA
- Young Investigator Award, American Federation of Clinical
Research, USA
- Research Fellow, the World Health Organization (WHO),
Switzerland
- Research Fellow, The Russian Agreement on Cultural Exchange,
Russia
- Institute for Health Research Fellowship, Canada
Appointments
- Research Associate, International Centre for Tropical Medicine,
Colombia 1983
- Post-Doctoral Fellow, BC Cancer Research Centre, Canada 1996
- Senior Research Associate, BC Cancer Research Centre, Canada
1999
- Research Scientist, University of British Columbia CDC, Canada
2002
- Senior Lecturer and Research Fellow, Griffith University,
Australia 2008
- Professor of Microbiology & Immunology, Alfaisal University,
Saudi Arabia 2011-present
Research Interests
- Vaccines that protect against intracellular infections such as
malaria and Leishmania and Chlamydia require strong cellular
responses based on T cells in addition to antibodies. Dendritic
cells are important immune cells that express many pattern
recognition receptors and are remarkable effective at processing and
presenting antigens to naïve T cells. My research explores these
unique properties of dendritic cells to design vaccines that target
intra cellular infections. This approach includes the identification
of protective vaccine candidate antigens, optimization of vaccine
adjuvants and implementation of innovative vaccine delivery systems.
Experimental vaccines based on dendritic cell approaches have been
demonstrated to be highly efficient and promise to rationalize the
way vaccines are prepared.
Current Projects
- A novel approach to Chlamydia trachomatis vaccine development:
targeting vaccines to dendritic cells (DCs) in vivo. This study
intends to prepare vaccines that target specific DCs subsets in
vivo. Antibodies recognizing DCs populations are conjugated to
Chlamydia antigens and delivered together with adjuvants in a
vaccine. This vaccine would trigger an immune response based on CD4+
and/or CD8+ T cells depending on the DCs groups targeted. The
project has been submitted to the Natural Health and Medical
Research Council of Australia for funding, 2012.
- Identification of novel vaccine adjuvants within a collection of
natural products. This study intends to identify vaccine adjuvants
within collections of natural products. It is based on the ability
of adjuvants to induce immunogenicity of dendritic cells. The
project is to be submitted to KACTS, Saudi Arabia.
- Identification of novel T cell protective antigens from
Leishmania major. Using a combination of dendritic cell technology
and the genome sequence of L. major, this project proposes to
isolate and identify T cell antigens from the surface MHC of
dendritic cells infected with Leishmania. To be submitted to KACTS,
Saudi Arabia.
Relevant publications:
- Rey-Ladino, J. Allen G. Ross, Allan W Cripps, Donald P. McManus
and Ronald Quinn, 2011. Natural Products and the search for vaccine
adjuvants, Vaccine, 29(38): 6464-71
- D.P. McManus, D. J. Gray, Y Li, G. M. Williams, Z. Feng, J.
Rey-Ladino, D. Stewart, & A.G. Ross (2010). Schistosomiasis in the
People's Republic of China: The Era of the Three Gorges Dam.
Clinical Microbiology Reviews, 23 (2): 442-466
- Jiang, X., Shen, C., Rey-Ladino, J., Yu, H. and Brunham, RC.
2008. Characterization of a dendritic cell line (JAWS II) and bone
marrow-derived dendritic cells in Chlamydia antigen presentation and
induction of protective immunity. Infection and Immunity, 78(6):
2392-401
- Karunakaran, KP., Jose Rey-Ladino, Nikolay Stoynov, Kyra Berg,
Caixia Shen, Xiozhou Jiang, Leonard, J. Foster and Robert C.
Brunham, 2008. The immune proteome of Chlamydia: discovery and
evaluation of novel T cell antigens. Journal of Immunology, 180(4):
2459-65
- Rey-Ladino, Jose, Xiaozhou Jiang, Brent Gabel, Caixia Shen and
Robert C.Brunham. 2007. Survival of Chlamydia muridarum within
dendritic cells. Infection and Immunity, 75(8):3707-14.
- Brunham Robert C., and Jose Rey-Ladino, 2005. Immunology of
Chlamydia infection: implications for a Chlamydia trachomatis
vaccine. Nature Reviews Immunology, 5:149-161
- Rey-Ladino, Jose, Koochesfahani KM, Shen C, Brunham RC, 2005. A
live and inactivated Chlamydia trachomatis mouse pneumonitis strain
induces the maturation of dendritic cells that are phenotypically
and immunologically distinct. Infection and Immunity, 73:1568-77.
- Reza MM, Jose Rey-Ladino (co-principal), 2003. Faye DL, Shaw D,
and Takei, F. Membrane cholesterol regulates LFA-1 function and
lipid rafts heterogeneity. Blood ,102:215-22.
- Rey-Ladino, Jose, Huber M, Liu L, Damen EJ, Krystal G, Takei F.
!999. The SH2-containing inositol-5’-phosphatase, SHIP, enhances
LFA-1 (CD11a/CD18)-mediated cell adhesion and defines two signaling
pathways for LFA-1 activation. Journal of Immunology, 162: 5792-99.
- Rey-Ladino, Jose, Pyszniak A, Takei F, 1988. Dominant-negative
effect of the lymphocyte function associated antigen-1 CD18
cytoplasmic domain on leukocyte adhesion to ICAM-1 and fibronectin.
Jorunal of Immunology, 160: 3494-3501.